DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Bonnefoi H, Grellety T, Tredan O. et al.
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer T(UCBG 12–1).
Ann Oncol 2016;
27: 812-818
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.